Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Xin Yi Sheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in Harbin, Heilongjiang Province. The company specializes in the development, manufacturing, and marketing of Traditional Chinese Medicine (TCM) and modern pharmaceutical formulations. Its product portfolio features a variety of dosage forms, including capsules, tablets, and granules, with a strong focus on cardiovascular and anti-inflammatory treatments. Key products include Xinnaokang Capsules for heart health and Compound Lonicera Granules for respiratory infections. The firm operates GMP-certified facilities and maintains a significant presence in the domestic Chinese healthcare market. Xin Yi Sheng integrates traditional herbal knowledge with modern manufacturing standards to provide therapeutic solutions for chronic and acute conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 黑龙江新医圣.